146 related articles for article (PubMed ID: 21692859)
21. Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study.
Abdou AG; Hanout HM
J Cutan Pathol; 2008 May; 35(5):445-51. PubMed ID: 18005174
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53 and apoptosis in discoid lupus erythematosus.
Zamolo G; Coklo M; Santini Dusevic D; Kastelan M; Batinac T; Materljan E; Brumini G
Croat Med J; 2005 Aug; 46(4):678-84. PubMed ID: 16100773
[TBL] [Abstract][Full Text] [Related]
23. Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.
Solé C; Gimenez-Barcons M; Ferrer B; Ordi-Ros J; Cortés-Hernández J
Br J Dermatol; 2016 Aug; 175(2):302-13. PubMed ID: 26972571
[TBL] [Abstract][Full Text] [Related]
24. OPG, RANK and RANK ligand expression in thyroid lesions.
Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemistry of ultrastructural changes in scarring lupus erythematosus.
Al-Refu K; Goodfield M
Clin Exp Dermatol; 2011 Jan; 36(1):63-8. PubMed ID: 20637030
[TBL] [Abstract][Full Text] [Related]
26. Perforin expression is upregulated in the epidermis of psoriatic lesions.
Kastelan M; Prpić Massari L; Gruber F; Zamolo G; Zauhar G; Coklo M; Rukavina D
Br J Dermatol; 2004 Oct; 151(4):831-6. PubMed ID: 15491424
[TBL] [Abstract][Full Text] [Related]
27. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
28. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
29. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
30. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
[TBL] [Abstract][Full Text] [Related]
31. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
32. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.
Koskenmies S; Järvinen TM; Onkamo P; Panelius J; Tuovinen U; Hasan T; Ranki A; Saarialho-Kere U
Lupus; 2008 Apr; 17(4):337-47. PubMed ID: 18413417
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.
Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin M predominance in cutaneous lupus erythematosus.
Kontos AP; Jirsari M; Jacobsen G; Fivenson DP
J Cutan Pathol; 2005 May; 32(5):352-5. PubMed ID: 15811120
[TBL] [Abstract][Full Text] [Related]
36. [Chronic lupus erythematosus, subacute cutaneous lupus].
Doutre MS; Beylot C
Rev Prat; 1990 Sep; 40(21):1930-4. PubMed ID: 2237183
[TBL] [Abstract][Full Text] [Related]
37. Expression of interleukin-17 is correlated with interferon-α expression in cutaneous lesions of lupus erythematosus.
Oh SH; Roh HJ; Kwon JE; Lee SH; Kim JY; Choi HJ; Lim BJ
Clin Exp Dermatol; 2011 Jul; 36(5):512-20. PubMed ID: 21631571
[TBL] [Abstract][Full Text] [Related]
38. Altered claudin expression is a feature of chronic plaque psoriasis.
Watson RE; Poddar R; Walker JM; McGuill I; Hoare LM; Griffiths CE; O'neill CA
J Pathol; 2007 Aug; 212(4):450-8. PubMed ID: 17582238
[TBL] [Abstract][Full Text] [Related]
39. Papular lesions and cutaneous lupus erythematosus: a comparative clinical and histological study using monoclonal antibodies.
McHugh NJ; Maddison PJ; MacCleod TI; Dean SG; James IE; Goulding NJ; Tan RS
J Rheumatol; 1988 Jul; 15(7):1097-103. PubMed ID: 2459383
[TBL] [Abstract][Full Text] [Related]
40. [Current diagnosis of cutaneous lupus erythematosus].
Haust M; Bonsmann G; Kuhn A
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1594-8. PubMed ID: 16823708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
